PROGYNY INC (PGNY)

US74340E1038 - Common Stock

31.72  -0.35 (-1.09%)

After market: 31.72 0 (0%)

Buy % Consensus

86

ChartMill assigns a Buy % Consensus number of 86% to PGNY. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 47.6. This target is 50.06% above the current price.
PGNY was analyzed by 16 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about PGNY.
In the previous month the buy percentage consensus was at a similar level.
PGNY was analyzed by 16 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 31.7243.4346.9247.6052.50 - 36.92% 47.92% 50.06% 65.51%
Up and Down Grades
Date Firm Action Rating
2024-04-17 Truist Securities Reiterate Buy -> Buy
2024-02-28 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-02-28 Keybanc Maintains Overweight -> Overweight
2024-02-28 Truist Securities Maintains Buy -> Buy
2024-02-26 Leerink Partners Initiate Outperform
2023-11-08 Keybanc Maintains Overweight -> Overweight
2023-11-08 Truist Securities Maintains Buy -> Buy
2023-10-09 JP Morgan Maintains Overweight -> Overweight
2023-09-27 Canaccord Genuity Initiate Buy
2023-09-14 Cantor Fitzgerald Maintains Overweight -> Overweight
2023-08-11 Truist Securities Maintains Buy -> Buy
2023-08-04 Keybanc Maintains Overweight -> Overweight
2023-05-22 BTIG Initiate Buy
2023-05-15 JP Morgan Maintains Overweight -> Overweight
2023-05-09 Cantor Fitzgerald Maintains Overweight
2023-05-09 B of A Securities Maintains Buy
2023-04-21 Cantor Fitzgerald Initiate Overweight
2023-01-05 SVB Leerink Downgrade Outperform -> Market Perform
2022-12-19 Keybanc Maintains Overweight
2022-11-18 JP Morgan Maintains Overweight
2022-09-16 Keybanc Maintains Overweight
2022-09-07 Truist Securities Initiate Buy
2021-12-02 Jefferies Initiate Buy
2021-09-30 Berenberg Initiate Buy
2021-09-28 Barclays Maintains Overweight
2021-08-25 Barclays Maintains Overweight
2021-08-12 Barclays Initiate Overweight
2021-08-06 SVB Leerink Maintains Outperform
2021-06-02 Guggenheim Downgrade Buy -> Neutral
2021-05-07 SVB Leerink Maintains Outperform